Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

12

Number of overlapping holdings

50.0%

% of PPH's 27 holdings also in XPH

29.3%

% of XPH's 40 holdings also in PPH

Overlap by Weight
Sector Drift (PPH minus XPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PPH
Weight
in XPH
Overlap
ELI LILLY & CO 11.8% 4.6% 4.6%
MERCK & CO. INC. 5.9% 4.6% 4.6%
PFIZER INC 4.5% 4.6% 4.5%
JOHNSON & JOHNSON 6.6% 4.4% 4.4%
BRISTOL-MYERS SQUIBB CO 4.4% 4.4% 4.4%

Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XPH
NOVO-NORDISK A/S-SPONS ADR 9.6%
ELI LILLY & CO 7.2%
ABBVIE INC 6.0%
ASTRAZENECA PLC-SPONS ADR 5.1%
NOVARTIS AG-ADR 4.7%
AMERISOURCEBERGEN CORP 4.7%
MCKESSON CORP 4.6%
SANOFI-AVENTIS-ADR 4.5%
GLAXOSMITHKLINE PLC-SPON ADR 4.5%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS 4.4%
PPH Underweight Relative to XPH
AXSOME THERAPEUTICS, INC. -5.0%
INTRA-CELLULAR THERAPIES INC -4.7%
ROYALTY PHARMA PLC CLASS A -4.6%
PERRIGO CO -4.0%
ORGANON & CO. -3.8%
CYMABAY THERAPEUTICS, INC. -3.7%
JAZZ PHARMACEUTICALS PLC -3.6%
CATALENT INC -3.6%
ELANCO ANIMAL HEALTH, INC. -3.5%
CORCEPT THERAPEUTICS INC -3.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY